45 medtech investors in Europe
We list 45 medtech investors in Europe as of November 2026: each was checked on its own website or an official register, and the list was last checked on 9 Nov 2026. The cities with the most head offices on this list are Paris (7), Dublin (3) and Munich (3).
Top 10 medtech investors in Europe, ranked by recent fund activity
Among firms with a published profile and a dated fund or deal in the last 24 months. The rule: Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns. The same rule orders the whole list; it is repeated in the method box.
HBM Partners
Type: Fund manager · HQ: Zug, Switzerland · Stages: Series A, Series B, Growth, Late stage · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: $2.8B (own site)
Portfolio news dated Oct 2026; $2.8B on file (own site); states medtech and medical devices as a focus; 1 named decision-maker on file.
Andera Partners
Type: Fund manager · HQ: Paris, France · Stages: Seed, Series A, Series B, Growth · Focus: Medtech, Biotech, Healthtech, Generalist · Latest activity: Portfolio news, Sep 2026 · Fund size or assets: €6.0B (own site)
Portfolio news dated Sep 2026; €6.0B on file (own site); states medtech and medical devices as a focus.
Truffle Capital
Type: VC firm · HQ: Paris, France · Focus: Medtech, Healthtech, Biotech, Fintech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: €500M (own site)
Portfolio news dated Oct 2026; €500M on file (own site); states medtech and medical devices as a focus; 3 named decision-makers on file.
Fountain Healthcare Partners
Type: VC firm · HQ: Dublin, Ireland · Stages: Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, Oct 2026 · Fund size or assets: €425M (own site)
Portfolio news dated Oct 2026; €425M on file (own site); states medtech and medical devices as a focus; 2 named decision-makers on file.
NLC Health Ventures
Type: VC firm · HQ: Amsterdam, Netherlands · Stages: Pre-seed, Seed · Focus: Medtech, Healthtech, Biotech · Latest activity: New fund, Sep 2026 · Fund size or assets: €300M (own site)
Latest fund filing dated Sep 2026; €300M on file (own site); states medtech and medical devices as a focus; 4 named decision-makers on file.
Hadean Ventures
Type: VC firm · HQ: Norway · Stages: Seed, Series A, Series B · Focus: Medtech, Healthtech, Biotech · Latest activity: New deal, Sep 2026 · Fund size or assets: €230M (own site)
Dated new deal in Sep 2026; €230M on file (own site); states medtech and medical devices as a focus; 3 named decision-makers on file.
Angelor
Type: VC firm · HQ: Lyon, France · Stages: Seed, Series A · Focus: Medtech, Healthtech, Biotech, Food and Beverage · Latest activity: New deal, Sep 2026 · Fund size or assets: €100M (own site)
Dated new deal in Sep 2026; €100M on file (own site); states medtech and medical devices as a focus; 1 named decision-maker on file.
819 Capital Partners
Type: VC firm · HQ: Deventer, Netherlands · Stages: Seed, Series A, Growth · Focus: Medtech, Healthtech, Biotech, Generalist · Latest activity: Portfolio news, Sep 2026 · Fund size or assets: €100M (own site)
Portfolio news dated Sep 2026; €100M on file (own site); states medtech and medical devices as a focus; 1 named decision-maker on file.
Lauxera Capital Partners
Type: VC firm · HQ: Paris, France · Stages: Growth · Focus: Medtech, Healthtech · Latest activity: New fund, May 2026 · Fund size or assets: €800M (own site)
Latest fund filing dated May 2026; €800M on file (own site); states medtech and medical devices as a focus; 4 named decision-makers on file.
Wellington Partners
Type: VC firm · HQ: Munich, Germany · Stages: Series A, Series B, Growth · Focus: Medtech, Healthtech, Biotech · Latest activity: Portfolio news, May 2026 · Fund size or assets: €210M (own site)
Portfolio news dated May 2026; €210M on file (own site); states medtech and medical devices as a focus; 8 named decision-makers on file.
First 22 of 45 medtech investors in Europe
| Investor | Type | HQ | Stagesour research | Focusour research | Latest fund or deal | Fund sizeas filed or stated | Checked | Contacts |
|---|---|---|---|---|---|---|---|---|
| HBM Partners | Fund manager | Zug, Switzerland | Series A, Series B, Growth, Late stage | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | $2.8B (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Andera Partners | Fund manager | Paris, France | Seed, Series A, Series B, Growth | Medtech, Biotech, Healthtech, Generalist | Portfolio news, Sep 2026 | €6.0B (own site) | 7 Nov 2026 | No contact on file |
| Truffle Capital | VC firm | Paris, France | Medtech, Healthtech, Biotech, Fintech | Portfolio news, Oct 2026 | €500M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock | |
| Fountain Healthcare Partners | VC firm | Dublin, Ireland | Seed | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | €425M (own site) | 7 Nov 2026 | 2 names, firm email · Unlock |
| NLC Health Ventures | VC firm | Amsterdam, Netherlands | Pre-seed, Seed | Medtech, Healthtech, Biotech | New fund, Sep 2026 | €300M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Hadean Ventures | VC firm | Norway | Seed, Series A, Series B | Medtech, Healthtech, Biotech | New deal, Sep 2026 | €230M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
| Angelor | VC firm | Lyon, France | Seed, Series A | Medtech, Healthtech, Biotech, Food and Beverage | New deal, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name · Unlock |
| 819 Capital Partners | VC firm | Deventer, Netherlands | Seed, Series A, Growth | Medtech, Healthtech, Biotech, Generalist | Portfolio news, Sep 2026 | €100M (own site) | 7 Nov 2026 | 1 name, firm email · Unlock |
| Lauxera Capital Partners | VC firm | Paris, France | Growth | Medtech, Healthtech | New fund, May 2026 | €800M (own site) | 7 Nov 2026 | 4 names, firm email · Unlock |
| Wellington Partners | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, May 2026 | €210M (own site) | 4 Nov 2026 | 8 names · Unlock |
| 415 Capital | VC firm | Munich, Germany | Series A, Series B, Growth | Medtech, Healthtech | Portfolio news, Nov 2026 | 7 Nov 2026 | 5 names, firm email · Unlock | |
| CRB Health Tech | VC firm | Madrid, Spain | Seed, Series A | Medtech, Healthtech, Biotech | New fund, Oct 2026 | 7 Nov 2026 | 5 names, firm email · Unlock | |
| TVM Capital Life Science | VC firm | Munich, Germany | Seed, Series A, Series B, Growth | Medtech, Healthtech, Biotech | Portfolio news, Sep 2026 | 7 Nov 2026 | 4 names, firm email · Unlock | |
| b2venture | VC firm | St. Gallen, Switzerland | Pre-seed, Seed, Series A | Medtech, AI, Fintech, Healthtech | Portfolio news, Oct 2026 | 7 Nov 2026 | 5 names, firm email · Unlock | |
| Gilde Healthcare | Fund manager | Utrecht, Netherlands | Series A, Series B, Growth | Medtech, Healthtech, Biotech, Climate Tech | New fund, Feb 2026 | €3.0B (own site) | 7 Nov 2026 | firm email · Unlock |
| XGEN Venture | VC firm | Milan, Italy | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Oct 2026 | 7 Nov 2026 | 3 names · Unlock | |
| TNO Ventures | Government or university fund | Netherlands | Pre-seed, Seed | Medtech, Deep Tech, AI, Climate Tech | Portfolio news, Sep 2026 | 7 Nov 2026 | firm email · Unlock | |
| SHS Capital | Fund manager | Tübingen, Germany | Growth | Medtech, Healthtech, Biotech | New fund, Feb 2026 | €270M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Mérieux Equity Partners | Fund manager | Lyon, France | Seed, Series A, Series B | Medtech, Healthtech, Biotech | Investment listed in 2026 | €150M (own site) | 7 Nov 2026 | 5 names, firm email · Unlock |
| Curie Capital | VC firm | Amstelveen, Netherlands | Seed, Series A | Medtech, Healthtech, Biotech | Portfolio news, Jun 2026 | 7 Nov 2026 | 2 names, firm email · Unlock | |
| Asabys Partners | VC firm | Barcelona, Spain | Medtech, Healthtech, Biotech | New fund, Jul 2026 | 7 Nov 2026 | 5 names, firm email · Unlock | ||
| Segulah Medical Acceleration (SMA) | VC firm | Stockholm, Sweden | Series A, Growth | Medtech, Healthtech | Portfolio news, Jun 2025 | €120M (own site) | 7 Nov 2026 | 3 names, firm email · Unlock |
You are seeing 22 of 45. The full list adds 23 more investors and 142 named decision-makers.
One-time payment. No subscription. No account.
Or get the free sample.
How these 45 break down
By European country
| European country | On this list | Share |
|---|---|---|
| France | 10 | 22% |
| Netherlands | 8 | 18% |
| Germany | 4 | 9% |
| Luxembourg | 4 | 9% |
| Ireland | 3 | 7% |
| Spain | 3 | 7% |
| Sweden | 3 | 7% |
| Switzerland | 2 | 4% |
By stage
| Stage | On this list | Share |
|---|---|---|
| Pre-Seed | 8 | 18% |
| Seed | 28 | 62% |
| Series A | 24 | 53% |
| Series B | 11 | 24% |
| Growth | 19 | 42% |
Stage is our research. A firm can back more than one stage.
By type
| Type | On this list | Share |
|---|---|---|
| VC firm | 32 | 71% |
| Fund manager | 7 | 16% |
| Government or university fund | 3 | 7% |
| Angel network | 2 | 4% |
Method and limits
- Source
- No row on this list rests on an SEC filing. All 45 have a website we checked. Filing date and fund size are SEC data where a filing exists. Stage, sector and check size are our research.
- Inclusion rule
- Organizations that back startups. Individuals, buyout funds and firms we found to be inactive are left out. Sector: the firm states medtech and medical devices as a focus on its own site, or we observed it in the firm's portfolio.
- Order
- Firms with a published profile come first. Activity score out of 100: recency of the latest fund filing or dated deal (40: within 3 months 40, 6 months 30, 12 months 20, 24 months 10), share of the observed portfolio in this sector (30; 15 when the sector is stated only), size of the fund on file on a log scale (20) and completeness of the public record (10). It is a measure of activity and fit, not of quality or returns.
- Last refreshed
- November 2026. Rows on this list were checked between 4 Nov 2026 and 9 Nov 2026.
- Fill rates
- Of 45 rows: stage 40, sector 45, fund size 19, website 45. In the paid file: named decision-makers on 39 rows, firm email on 37, LinkedIn page on 33, check size on 14.
- Corrections
- Email hello@theinvestordatabase.com or use the update form. We act within 5 working days.
Questions
How many medtech investors in Europe are there?
We list 45 as of November 2026. 25 of the 45 have a fund filing or a dated deal in the last 12 months. The cities with the most are Paris (7), Dublin (3) and Munich (3).
Which medtech investors in Europe raised a new fund in the last 12 months?
None of the 45 has a fund filing dated in the last 12 months on file; 25 have other dated activity in that time (fund announcement, new deal and portfolio news), most recently 415 Capital (portfolio news, Nov 2026), HBM Partners (portfolio news, Oct 2026) and XGEN Venture (portfolio news, Oct 2026).
What is the typical fund size of medtech investors in Europe?
None of the 45 discloses a fund size on an SEC Form D, so there is no median to give. 19 rows carry a size or assets figure from another public source, for example HBM Partners at $2.8B (own site) and Andera Partners at €6.0B (own site).
Which stage do most medtech investors in Europe back?
Of the 40 with a stage on file, seed (28), Series A (24) and growth-stage (19). A firm can back more than one stage, and 5 rows have no stage on file yet.
Where does the data on medtech investors in Europe come from and how often is it updated?
All 45 rows were checked on the firm's own website, with official registers and national venture capital association directories as the starting point. Filing date and fund size come from the filing. Stage, sector and check size are our research. Rows on this list were last checked on 9 Nov 2026 at the latest. The whole file is re-verified twice a year.
Can I download the list of medtech investors in Europe as a spreadsheet?
Yes. The file holds all 45 rows in Excel and CSV, with 142 named decision-makers and 37 firm emails, for $49 one-time. 22 rows are free on this page.
Related lists
Consumer investors in Europe (65)Edtech investors in Europe (35)Proptech investors in Europe (37)Climate tech investors in Europe (250)Deep tech investors in Europe (299)Hardware investors in Europe (18)Impact investors in Europe (52)Food and beverage investors in Europe (67)Medtech venture capital firms in the US (350)Healthtech investors in Europe (291)SaaS investors in Europe (239)AI investors in Europe (230)Fintech investors in Europe (140)Energy investors in Europe (103)B2B investors in Europe (102)Biotech investors in Europe (89)Cybersecurity investors in Europe (64)Agritech investors in Europe (63)
Not sure this is the right list? Describe your raise in the investor matching tool and get a shortlist. The link opens it set to medtech and medical devices and Europe. Guide: how to build an investor list. Markdown version of this page.
Check the quality first
A free sample of 100 investors, every column, with sources and dates.